Tellez M, Cooper J, Edmonds C
Medical Research Council, Northwick Park Hospital, Harrow, Middlesex, UK.
Clin Endocrinol (Oxf). 1992 Mar;36(3):291-4. doi: 10.1111/j.1365-2265.1992.tb01445.x.
We aimed to study the effect of cigarette smoking on the prevalence and severity of Graves' ophthalmopathy (GO).
One hundred and fifty-five newly diagnosed patients with Graves' disease (GD) were diagnosed clinically and by routine biochemical methods. Twenty-five per cent (39) were of Asian origin.
Eye signs were classified according to the American Thyroid Association Classification. A detailed smoking questionnaire and data from hospital notes were used to calculate an index of cigarette consumption.
Thirty-four per cent of all patients had Graves' ophthalmopathy, and the prevalence in males (26%) and females (36%) did not differ significantly. There was a prevalence of 42% among Europeans compared to 7.7% in Asians (P = 0.0002). The overall risk for Europeans for developing Graves' ophthalmopathy was 6.4 (1.78-22.7 confidence interval) times higher than for Asians. Corrected for the ethnic factor the increased risk from smoking for Europeans was 2.4 (1.12-5.18, 95% confidence interval) times higher. There was a significant dose effect (P = 0.008).
The present findings confirm an effect of cigarette smoking on Graves' ophthalmopathy and in addition show that Europeans have a substantially greater risk of developing Graves' ophthalmopathy than have Asians.
我们旨在研究吸烟对格雷夫斯眼病(GO)患病率和严重程度的影响。
155例新诊断的格雷夫斯病(GD)患者通过临床及常规生化方法确诊。其中25%(39例)为亚洲裔。
根据美国甲状腺协会分类法对眼部体征进行分类。使用详细的吸烟调查问卷及医院病历数据计算吸烟指数。
所有患者中34%患有格雷夫斯眼病,男性患病率(26%)和女性患病率(36%)无显著差异。欧洲人的患病率为42%,而亚洲人为7.7%(P = 0.0002)。欧洲人患格雷夫斯眼病的总体风险比亚洲人高6.4倍(置信区间1.78 - 22.7)。校正种族因素后,欧洲人因吸烟增加的风险高2.4倍(1.12 - 5.18,95%置信区间)。存在显著的剂量效应(P = 0.008)。
目前的研究结果证实吸烟对格雷夫斯眼病有影响,此外还表明欧洲人患格雷夫斯眼病的风险比亚洲人大得多。